Viewing Study NCT00389766

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:43 PM

Ignite Modification Date: 2025-12-28 @ 1:11 AM

Study NCT ID: NCT00389766

Status: WITHDRAWN

Last Update Posted: 2013-07-10

First Post: 2006-10-18

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma

Sponsor: Children's Cancer and Leukaemia Group

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module